COMPUMED RECRUITS HEALTHCARE INDUSTRY VETERANS FOR TOP ENGINEERING AND SALES POSTS
Scott Evers and Henky Wibowo Tapped to Spearhead Sales and Product Development Growth
LOS ANGELES, July 12 2005 -- CompuMed, Inc. (CMPD.OB) -- a medical informatics company serving the healthcare community with diagnostic software solutions -- today announced two key additions to its management team. Joining the company are Scott Evers as vice president of sales and Henky Wibowo as vice president of engineering. In addition, Xiaoli Bi, who formerly served as the Company's vice president of technology, has been promoted to the newly created position of chief technology officer.
"We are very pleased to have Scott and Henky on board to help fuel CompuMed's sales and product development growth," said CompuMed CEO Jerry McLaughlin. "They bring proven track records, along with the ideal blend of skills and experience to help us optimize our strategy, particularly with respect to CompuMed's OsteoGram(R) system for osteoporosis screening, diagnostics and monitoring."
McLaughlin added, "We also are pleased to promote Xiaoli Bi. CompuMed will continue to benefit from her broad expertise as she assumes an even greater role at the Company."
In his new post, Scott Evers will be responsible for CompuMed's global sales efforts, with a focus on the Company's OsteoGram products. He joins CompuMed with more than 10 years of senior level management experience in the digital medical imaging field. Most recently, he served as vice president of North American sales for Orex Computed Radiography, a wholly owned subsidiary of the Kodak Health Group. While at Orex, Evers increased previous quarterly sales by more than 300% in each of the first two quarters of his tenure. He also served as executive vice president of sales for AuntMinnie.com, the leading Internet portal for medical imaging professionals. While at AuntMinnie.com, he increased annual revenue by more than 200% in his first 12 months. Other relevant experience includes working for computed radiography provider Lumisys, Inc., where he was responsible for global sales of the company's Desktop CR(TM) (Lumisys was acquired by Kodak in 2001). Mr. Evers earned a B.A. in communication and business economics from the University of California, Santa Barbara.
Henky Wibowo brings more than 14 years of senior level experience to his new post, where he will be responsible for overseeing all of CompuMed's product development activities. He is a healthcare software expert who has built and managed successful start-up companies. Most recently, he was co-founder and chief technology officer of iAtrogenix -- a provider of healthcare information management systems. While at the Company, he served as the principal architect of its secured messaging frameworks. He also served as vice president of engineering/software at Lumisys, Inc., where he spearheaded software development for the Company's industry leading computed radiography platform. Other relevant experience includes serving as vice president of engineering at CompuRad, where he was also the Company's first employee. While at CompuRad, he designed and developed the first PC-based DICOM client server teleradiology software utilizing 32-bit Windows COM-based frameworks. Mr. Wibowo earned a B.S. (with high scholarship) in electrical and computer engineering from Oregon State University, and a M.S. in electrical and computer engineering from the University of Arizona.
Before today's announcement, Xiaoli Bi served as CompuMed's vice president of technology. She joined the Company in April 2001, and was the principal designer responsible for development of its OsteoGram software program. In her new post, she will be responsible for new product evaluation/specification, licensing agreement technical support and the Company's expanding strategy in China. Prior to joining CompuMed, she worked with global pharmaceutical giant Merck & Company. Ms. Bi earned a B.S. in mechanical engineering from TongJi University (Shanghai, China) and a M.S. in biological systems engineering from the University of Nebraska-Lincoln.
About CompuMed:
Founded in 1973, CompuMed, Inc. (BB:CMPD) is a leading provider of computer-aided telemedicine and diagnostics technology. The Company's core products are the OsteoGram and CardioGram systems. The OsteoGram, which is cleared by the FDA for commercial use, is an accurate and precise technology for low-cost osteoporosis testing. The CardioGram system remotely interprets electrocardiograms and is used by private practice, government and corporate healthcare providers nationwide. CompuMed is headquartered in Los Angeles. Visit CompuMed at www.compumed.net or call (310) 258-5000.
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning CompuMed's plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are not statements of historical fact. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, ability to raise capital, the availability of appropriate acquisition candidates and/or business partnerships, economic conditions, the impact of competition and pricing, capacity and supply constraints or difficulties, government regulation and other risks identified in the Company's filings with the Securities and Exchange Commission. All such forward-looking statements are expressly qualified by these cautionary statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof, except as required by law.
CONTACT: Erik Deutsch - Tellem Worldwide, +1 (310) 479-6111 x.15, edeutsch@tellem.com